Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector b-catenin. Akt phosphorylates b-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of b-catenin.
The failure of most current therapies to cure cancer has led to the hypothesis that treatments targeted at malignant proliferation spare a more slowly cycling 'cancer stem cell' population that has the ability to regenerate the tumor 1 . Recently, cancer stem cells have been identified and shown to seed tumors upon transplantation into a secondary host [2] [3] [4] . However, little is known about the process by which mutation(s) in a stem cell result in primary tumor initiation.
Although there are many 'causes' of intestinal cancer, it is well established that almost all cases begin with the development of benign polyps, mainly involving benign neoplastic proliferation of epithelium. The epithelium of the small intestine is composed of a proliferation compartment (crypt) and a differentiation compartment in the villus (Fig. 1a) . ISCs, located near the crypt base and above Paneth cells 5, 6 , give rise to enterocytes, goblet cells, enteroendocrine cells and Paneth cells [6] [7] [8] . Intestinal polyposis features a substantial increase in the number of crypts (crypt expansion) and a reduction in epithelial cell differentiation 6, 7, 9, 10 . A key question 7, 9, 11 is whether stem cells are involved in the abnormal crypt expansion during polyp initiation.
Studies of human hereditary intestinal polyposis syndromes (which typically, but not uniformly, predispose affected individuals to gastrointestinal cancers) and equivalent animal models have provided substantial insight into the genetic control of intestinal homeostasis, polyposis and cancer. Polyposis can result from impaired bone morphogenic protein (BMP) signaling 9, 10, 12 or by overactivation of Wnt-b-catenin signaling 13 . Wnt-b-catenin signaling exerts positive control on multiplication of both stem cells and crypts 13, 14 , whereas BMP signaling restricts stem cell number and prevents polyposis, in part by suppressing Wnt signaling 9, 10 .
Cowden disease (OMIM #158350) is a rare autosomal dominant disorder featuring multiple hamartomatous lesions, including intestinal polyps. Cowden disease results from mutation in the gene encoding PTEN 15 , a lipid and protein phosphatase that acts as a negative regulator of the phosphatidylinositol-3 kinase (PI3K)-Akt pathway 16 . The roles of PTEN and Akt in intestinal homeostasis and polyposis have not been defined, but there is evidence that they could be key players in the interplay between BMP and Wnt signals. Mutation of BMPR1A can result in a Cowden-like syndrome resembling loss of PTEN 17 . BMP signaling may in part be mediated by inhibition of PI3K-Akt activity via positive regulation of PTEN 9, 18, 19 . In turn, PTEN inhibits, whereas Akt enhances, the nuclear localization of b-catenin 20, 21 , consistent with our previous model in which Akt assists Wnt signaling in activation of b-catenin in ISCs 9, 19 .
In this study, we used the PTEN conditional inactivation mouse model 22 to define the role of the PTEN-Akt pathway in the intestine. We implicate PTEN-deficient stem cells in the origin of polyposis and establish a molecular mechanism by which the PTEN-Akt and Wntb-catenin pathways coordinate to regulate intestinal homeostasis.
RESULTS

Induced inactivation of PTEN leads to intestinal polyposis
In this study we used the conditional inactivation mouse, model in which exon five of Pten is 'floxed' (Pten fl/fl) , to define the role of the PTEN-Akt pathway in the intestine. To determine the time course of PTEN loss, we generated Mx1-Cre:Pten fl/fl mice 22 carrying a Z/EG reporter, so that Cre-mediated Pten deletion would be reported by the expression of green fluorescent protein (GFP). We induced gene deletion at or before weaning with polyinosinic-polycytidylic acid (pIpC), which provokes innate immune and inflammatory responses and generates interferon that, in turn, activates Cre expression 23 . We first detected GFP + cells 3 d after completion of pIpC treatment (day 3). Costaining with the stem cell marker Musashi1 (referred to hereafter as 'Musashi') 24 confirmed that recombination had occurred in ISCs (Fig. 1b) . Initially, GFP + epithelial cells were clustered primarily in the crypt bottom or located at the transition zone between crypts and villi (Fig. 1b,c) . The GFP + domains expanded to include groups of crypts on day 5 (Fig. 1d) . By day 18, the GFP + domains encompassed crypts and villi and a minority of the crypts and villi from which PTEN had been lost appeared dysmorphic (Fig. 1e) . At day 30, the GFP + epithelium likewise contained both dysmorphic and apparently normal crypts and villi (data not shown). We found a limited number of stromal cells to be GFP + (Fig. 1c) . We confirmed successful targeting of Pten in the intestine by PCR analysis (Fig. 1f) , which showed deletion of Pten exon 5 encoding the phosphatase motif 22 .
We detected multiple polyps (Fig. 1g) in the small intestinal tract of Pten homozygous mutant mice (referred to as 'PTEN mutants'; Mx1-Cre + ;Pten fl/fl ) 1 month after completion of pIpC injection (n ¼ 15) but did not observe them in the control group (Mx1-Cre + ;Pten fl/+ or Mx1-Cre -;Pten fl/fl mice) (data not shown). Histologically, the polyps showed a large excess of crypt-like units at their base as well as an aberrant positioning of crypts along the edges of villi. There were also overgrowth and insertions of stromal cells from the base of the polypoid mass, a typical feature of hamartoma 25 (Fig. 1h) . The stromal insertions reliably contained smooth muscle a-actin-positive myofibroblasts, whereas the B220-positive lymphocyte component varied from negligible to pronounced (data not shown). Our subsequent analysis of the polyposis focuses on the PTEN mutant epithelium.
PTEN controls cell cycle in intestinal crypts PTEN inhibits cell proliferation through suppression of PI3K and Akt activity 16 . Therefore, we assessed the proliferation state of cells in the intestinal polyp regions of the PTEN mutants by labeling actively cycling cells with a 3-h pulse of BrdU. In normal crypts, BrdU + cells were limited to a narrow proliferation zone containing the transit amplifying cells (TACs) (Fig. 1i) . However, in PTEN-deficient polyps, the BrdU + cells were spread widely within the multiple crypt-like structures (Fig. 1j) , the proliferating tissue appeared hyperplastic compared with the linear arrangement of proliferating cells in normal crypts (Fig. 1k) and the proliferative index of the epithelial cells (number of BrdU + cells/(number of BrdU + cells + number of BrdU -cells)) was substantially higher (19.4% versus 53.2%; P o 0.01) than in controls (Fig. 1l) .
We next examined the relationship between PTEN expression and cell cycle status. PTEN can be phosphorylated at its C terminus by casein kinase II, which impairs its recruitment to the plasma membrane, where it antagonizes PI3K-Akt activity 26 . Thus, the most active forms of PTEN are nonphosphorylated but can be detected by a phosphorylation-insensitive antibody (pan-PTEN). We found pan-PTEN immunostaining in two distinct cell populations. Multiple pan-PTEN-positive cells were present in a portion of crypt TACs, the majority of which were BrdU - (Fig. 2a,b) . We also observed pan-PTEN + BrdU -cells toward the base of the crypt in the expected ISC location (Fig. 2a,c) . The presence of PTEN expression in the less actively proliferating cells of the crypt, along with the increase in the proportion of proliferating cells in PTEN mutants, suggests that PTEN acts in TACs as a negative regulator of the cell cycle. In our mutants 22 , loss of PTEN function is expected to result in activation of Akt (as measured by the phosphorylated form of Akt-Thr473 (hereafter 'p-Akt') and phosphorylation of the Akt downstream target GSK3b at Ser9 ('p-GSK3b') 16 . Indeed, protein blot analysis demonstrated increased levels of p-Akt and p-GSK3b in the PTEN-deficient mice (Fig. 2d) . We found that cyclinD1 and c-Myc, two downstream targets of the PI3K-Akt pathway 27 that are important for G 1 /S phase transition, were upregulated (Fig. 2d) in intestines from PTEN-deficient mice relative to controls. By microarray analysis, we identified genes with the ontology term 'regulation of cell cycle' that were upregulated or downregulated (more than twofold) in PTEN-deficient polyp areas compared with control intestine (Fig. 2e) . This uncovered coordinated changes in gene expression in the PTEN mutants: notably, upregulation of Ccnd3 (which encodes cyclinD3) and Cdk6 (encoding a cyclinD interacting factor) and increased expression of several key genes involved in the cell cycle G 1 /S checkpoint (Fig. 2e) . Downregulation of JunB in PTEN mutants is notable, as phenotypic similarity between PTEN and JunB mutants in hematopoetic stem cells suggests a functional link between these genes 28, 29 .
In summary, the increased proliferation rate in the polyps of PTEN mutants is attributable to a requirement for PTEN as a negative cell cycle regulator within the TACs of the crypt. Loss of PTEN results in increased Akt activity and increased expression of cyclinD1, Myc and additional genes acting at the G 1 /S transition.
Musashi + stem and progenitor cells initiate polyp formation
The observations that PTEN is expressed in ISCs ( Fig. 2c ; ref. 9) and that PTEN loss results in polyposis raise the possibility that PTENdeficient ISCs are responsible for polyp formation. To test this hypothesis, we tracked ISCs using the marker Musashi 24 . In normal intestinal crypts, we detected two classes of Musashi + cells by a polyclonal antibody to Musashi (anti-Musashi) (Chemicon; cat. no. AB5977). As expected, we detected many Musashi + crypt cells at the ISC position and found that they could be costained for long-term retention of BrdU (BrdU-LTR) (Fig. 3a) , but we also observed some isolated Musashi + BrdU-LTR -cells (potentially progenitor cells) higher in the crypt (Fig. 3a) and in the transition zone between crypt and villus ( Supplementary Fig. 1 online) . Rat monoclonal antiMusashi yielded a slightly broader pattern of signal but had a similar distribution of strongly positive cells 24 ( Supplementary Fig. 2 online) . The enhanced BrdU-LTR in Musashi + ISCs, compared with progenitors, suggests that the ISCs are more frequently in a prolonged quiescent state. Nevertheless, Musashi + 'progenitors' shared multiple molecular characteristics with ISCs (see below and Supplementary Fig. 1 ) and will be considered together as 'Musashi + ISCs and progenitors' (M + ISC/p). To support ongoing intestinal regeneration, ISCs need to be able to change from quiescence to an active state in which they can undergo division. PTEN-deficient M + ISC/p cells cycle far more often than their normal counterparts: the proliferation cell marker Ki67 labeled 24% of the M + ISC/p cells with mutant PTEN but labeled only 2%-4% of the control M + ISC/p cells ( Fig. 3b-d ). This marked increase in proliferation may reflect an increased rate of cell cycle entry, more rapid progression or both.
Crypt expansion in colon cancer and polyposis can be caused by 'bottom-up' crypt fission (division of an existing crypt starting at its base), or by 'top-down' de novo crypt formation (budding of a new crypt from a crypt or villus) 9, 10, [30] [31] [32] [33] . We found that both mechanisms of crypt expansion occurred in PTEN-deficient intestines and were associated with an excessive production of M + ISC/p cells ( Fig. 3e-o) .
Dissociation of PTEN-deficient polyps showed that crypts were undergoing fission (Fig. 3e) or budding ( Fig. 3i) at a significantly higher rate than in controls (Fig. 3l) . M + ISC/p cells, a rare population of cells in normal intestine ( Supplementary Fig. 1 ), still formed only a minor component of the PTEN-deficient polyps but were found in clusters that seemed to be seeding the formation of new crypts. In examples of crypt fission, we observed M + ISC/p cells forming the apex Signal as a multiple of average for all samples of the ridge between crypts, suggesting that these cells are central to the fission process (Fig. 3f-h and Supplementary Fig. 3 online) . In the de novo formation of crypt-like structures in either crypts or villi (crypt budding), we found that small branches in the polyps (newly forming crypts) (Fig. 3j,k ,m,n and Supplementary Fig. 3 ) contained pairs or small groups of M + ISC/p cells along with other cycling and noncycling cells, suggesting stem cell-directed growth (Fig. 3k,n,o) . We also observed groups of Musashi + cells in villi where invagination was being initiated (Fig. 3j and Supplementary Fig. 3 ). Hence, in both crypt fission and crypt budding, we found Musashi + cells at the initiation points of newly forming crypts (Fig. 3h,o) .
PTEN-Akt pathway linked to ISC/p cell number and behavior
To help define the molecular link between loss of PTEN and a change in ISC/p cell behavior, we focused on the pathways downstream of PTEN-Akt leading to b-catenin-dependent transcription and cell cycle entry and progression (Fig. 4) . The phosphorylated forms of PTEN and Akt, along with the adaptor protein 14-3-3z, have been found in ISCs 9, 19 . Extending these findings, we found that cells in the ISC position, as well as a limited number of progenitor cells higher in the crypt, were highly positive for phosphorylated PTEN (p-PTEN), p-Akt, p-GSK3b, 14-3-3-z and Musashi (Fig. 4a -e,h and Supplementary Fig. 1 ). We observed lower amounts of p-Akt and p-GSK3b signal in the adjacent TACs (Fig. 4e,h ). Thus, a portion of M + ISC/p cells have high Akt 9 activity and correspondingly high amounts of p-GSK3b. Similar colocalization studies established that ISCs with high Akt activity (p-Akt + or p-PTEN + ) were commonly strongly positive for nuclear cyclinD1 and nuclear Cdkn1b or nuclear plus cytoplasmic Cdkn1b (p27 Kip1 ) (Fig. 4c,d) . In PTEN-deficient polyps, cells intensely positive for p-Akt and p-GSK3b were more frequent and were found at different depths within the same crypt and in unusual clusters (Fig. 4f,g,i,j) . Staining of adjacent sections showed a close correspondence between the two markers ( Fig. 4g,j) . Thus, loss of PTEN function increases the number and alters the distribution of ISC/p cells engaged in active Akt signaling.
Phosphorylation by Akt inactivates GSK3b, helping the Wnt signal to permit b-catenin to escape proteasome-mediated degradation and facilitating its nuclear translocation and involvement in transcriptional regulation 21 (Fig. 4u) . We assessed b-catenin-mediated transcriptional activity using the transgenic reporter Top-Gal, in which b-catenin and T cell factors (TCFs) cooperatively drive b-galactosidase expression. In PTEN mutants, the number of Top-Gal + cells was increased, and we detected Top-Gal expression, normally a property of ISCs or Paneth cells, ectopically in the villi (Fig. 4k-m and Supplementary Fig. 4 online) .
Akt might promote M + ISC/p cell proliferation by upregulating the expression of cyclinD1 by means of the mammalian target of rapamycin (mTor) or via enhanced b-catenin activity 27, 34 . Another possible mechanism is inactivation of the cycle-dependent kinase inhibitor p27 kip1 , as phosphorylation of p27 kip1 by Akt at Thr157 induces its nuclear export 35 (Fig. 4v) .
A high amount of nuclear-localized cyclinD1 is normally a property of the relatively slow-cycling (Ki67 -) M + ISC/p cells, whereas lower amounts of cyclinD1 are found in the more proliferative TACs (Fig. 4n and Supplementary Fig. 4 ). Mirroring the changes in active Akt signaling and Top-Gal activity, PTEN-deficient polyps contained an abnormally high number and disorganized cluster arrangement of cells with high levels of nuclear cyclinD1 (Fig. 4o,p) . Likewise, there was a higher number and altered distribution of cells with nuclear p27 kip1 (Fig. 4q-s) . Owing to the limited performance of available antibodies, we were unable to determine the Thr157 phosphorylation status of p27 kip1 in tissue sections, but by protein blot we found that PTEN deficiency in the intestine resulted in an overall increase in both p27 kip1 and Thr157-phosphorylated p27 kip1 (Fig. 4t) . Together, these results are consistent with the loss of PTEN (i) increasing the numbers of stem and progenitor cells, (ii) increasing the proportion of such cells with high amounts of nuclear cyclinD1 and/or nuclear p27 kip1 or (iii) affecting both the number and cell cycle status of this cell population.
Akt phosphorylates the C terminus of b-catenin at Ser552
In a variety of systems, including the intestine, nuclear localization of b-catenin is believed to be a key event in stem cell activation 9, 36 . Thus, we sought to define the interaction between the PTEN-Akt pathway and b-catenin nuclear localization. We have proposed that Akt coordinates with Wnt signaling and assists in the activation of b-catenin in ISCs 9 , either through phosphorylation of GSK3b (ref. 37) or by phosphorylation of b-catenin itself 19 .
We identified a putative Akt phosphorylation site at Ser552 (Fig. 5a) , and lowerstringency searches identified additional putative Akt sites at Thr217, Thr332 and Ser675 (data not shown). Using a liquid chromatography-mass spectrometry assay, we found that Ser552 of b-catenin is phosphorylated by Akt in vitro (Fig. 5b,c) . The phosphorylation of b-catenin by Akt can prime b-catenin for 14-3-3z binding and further stabilization 19 . The Arg-Arg-Thr-Ser sequence containing Ser552 forms a phosphoserine motif that serves as an optimal recognition site for 14-3-3z (ref. 38) .
To assay for b-catenin phosphorylated by Akt at Ser552, we developed and characterized a phospho-specific antibody (antip-b-cat-Ser552). In immunoprecipitation experiments (Fig. 5d) performed with purified intestinal crypts, anti-p-b-cat-Ser552 precipitated forms of b-catenin that could be recognized by an existing antibody that recognizes b-catenin not phosphorylated at the N terminus, which is typically enriched in the nucleus 39 . This indicates that intestinal crypts contain a population of b-catenin molecules that are phosphorylated on Ser552 but not phosphorylated at the N terminus. On protein blots, anti-p-b-cat-Ser552 detected b-catenin, as expected, and we obtained efficient blocking of the signal when we preincubated the antibody with a phosphopeptide for the antigen but not when we used the equivalent non-phosphopeptide, indicating that the antibody is phospho-specific (Fig. 5e) . Use of this antibody demonstrated that polyps of PTEN mutants had higher levels of b-catenin phosphorylated at Ser552 (p-b-cat-Ser552) than control intestine (Fig. 5e) .
Nuclear localization of b-catenin phosphorylated at Ser552
We next explored the relationship between Ser552 phosphorylation and b-catenin nuclear localization and activity (Fig. 6) . Nuclear extracts of intestinal crypts contained p-b-cat-Ser552, and we detected higher levels in PTEN mutants than in controls (Fig. 6a) . Immunohistochemistry showed strong spatial and subcellular localization of anti-p-b-cat-Ser552, with intense nuclear signal present in ISC/p cells and occasionally also in Paneth cells (Fig. 6b and Supplementary Fig. 4) . The antigen peptide blocked this signal, confirming the specificity of the antibody (Fig. 6c) . We also observed cells with lower levels of signal in a perinuclear pattern in some crypt cells ( Supplementary Fig. 4) . Consistent with our immunoprecipitation experiments, the active (that is, not phosphorylated at the N terminus) and p-b-cat-Ser552 forms of b-catenin exhibited similar distributions in intestinal crypts. We observed N-terminally nonphosphorylated b-catenin in the nuclei of M + ISCs (Fig. 6d) , in dividing ISCs (Fig. 6f) and in a subset of cells in other crypt positions (for example, in the Paneth cell in Fig. 6f) . The antibody to the p-b-cat-Ser552 form likewise detected nuclear b-catenin in Ki67 -ISCs (Fig. 6e) and in dividing ISCs (Fig. 6g) but also in cells at other crypt positions ( Supplementary Fig. 4) . Regardless of the antibody used, we observed ISCs with nuclear b-catenin undergoing division perpendicular to the plane of the epithelium (a feature of asymmetric division) and in close proximity to a mesenchymal cell (a putative stem cell niche) (Fig. 6f,g ). In pairs of asymmetrically dividing or recently divided ISCs (based on the expression of Musashi or nuclear p27 kip1 and on relative position), both cells were usually positive for nuclear p-b-cat-Ser552, but we also occasionally observed pairs of nuclear p27 kip1 -positive cells in which only the cell distal to the mesenchymal cell had nuclear p-b-cat-Ser552 ( Supplementary Fig. 4) . Use of alternative b-catenin antibodies in costaining experiments showed that ISCs could also have a membranous or cytoplasmic, rather than nuclear, distribution of b-catenin ( Supplementary Fig. 4 ).
For cells in the ISC position, but not for Paneth cells, we found that Top-Gal expression was strongly correlated with Akt activity (Fig. 6h,i) and p-b-cat-Ser552 nuclear localization (Fig. 6j,k) . This was most readily apparent in PTEN mutants, in which ISCs are more frequently positive for p-Akt, p-b-cat-Ser552 and Top-Gal activity. Based on our biochemical and immunostaining data, we propose a molecular pathway by which the Wnt and PTEN-Akt pathways interact to control b-catenin nuclear localization and transcriptional activity in the M + ISC/p cell (Fig. 6l) . In these cells, b-catenin exists in a range of states, and the nuclear forms may lack phosphorylation at the N terminus, may be phosphorylated towards the C terminus by Akt or may have both of these properties (Fig. 6m) .
Cells with nuclear p-b-cat-Ser552 initiate crypt expansion
In PTEN-deficient polyps, we observed that cells with nuclear p-b-catSer552 were greater in number and abnormally localized ( Fig. 7 and Supplementary Fig. 5 online) , similar to our findings with Musashi and with markers of an active Akt pathway. Per unit length of intestine, the PTEN-deficient polyps contained twice as many cells with a nuclear anti-p-b-cat-Ser552 signal as in control intestines ( Supplementary Fig. 5 ). PTEN loss had less effect on the number of such cells per crypt, suggesting that the overall increase is correlated with the increased number of crypts per unit length in the mutants. Consistent with this relationship, in the PTEN mutants, the cells with nuclear p-b-cat-Ser552 were frequently clustered together and were found at sites of crypt fission (Fig. 7a,b) and at sites of invagination where new crypts were budding from the sides of villi or crypts (Fig. 7c) . Because fission and budding can be difficult to recognize from sections, we isolated examples of crypt fission or budding from the mutant polyps and then used immunofluorescence and confocal microscopy to identify cells with nuclear p-b-cat-Ser552. In crypt fission samples, we found cells with nuclear p-b-cat-Ser552 at the apex of the ridge dividing the crypts (Fig. 7d and Supplementary Video 1 online) . In crypt budding, they were present at the junction between newly forming and parent crypts (Fig. 7e and Supplementary  Video 2 online) . ISC/p cell overproduction and intestinal polyposis initiation PTEN loss results in a higher number and altered distribution of the M + ISC/p cell population. This increase could simply be due to their increased proliferation but might also involve more frequent symmetric division. Changes in the M + ISC/p distribution may be due to the mutant stem cells being more mobile, consistent with the known role of Akt in governing cell migration 16 . Alternatively, descendents of PTEN-deficient ISCs may retain or reacquire ISC properties, yielding aberrantly localized M + ISC/p cells, a process possibly involving secondary mutation. The behavior of PTENdeficient ISCs resembles that of PTEN-deficient hematopoietic stem cells, which cycle more actively than normal and are impaired in their ability to lodge in bone marrow niches 29 . We conclude that in stem cell populations, PTEN functions to negatively regulate the cell cycle 29, 40, 41 and that sometimes this is coupled with control of stem cell location 29 .
Both crypt fission and crypt budding feature M + ISC/p cells at the initiation site, indicating a central role for these stem cells in the initiation of polyposis. Crypt fission, a component of normal intestinal growth and repair as well as a feature of polyposis, has been suggested to occur when the number of ISCs in a crypt exceeds some threshold capacity 7 , and our data validate this concept. Similarly, we propose that aberrantly located Musashi + cells direct the de novo budding morphogenesis of crypt-like structures from existing villi or crypts. This budding process will probably share some of the molecular and cellular characteristics of the initial formation of crypts during intestinal development, in which Musashi + cells demonstrate a similar distribution 24, 42 .
Wnt and PTEN-Akt pathways cooperate in ISC activation
The nuclear localization of b-catenin is considered a critical event in stem cell activation and, therefore, for homeostasis of the intestine 9, 36 . The highly restricted intestinal patterns of nuclear b-catenin and its transcription activity (shown by Top-Gal) are puzzling, as many Wntpathway components are expressed rather broadly or in gradients 43 , and the widespread distribution of the phosphorylated form of Wnt coreceptor Lrp6 suggests that all proliferating cells in crypts are exposed to Wnt signaling 9 . Akt, active in M + ISC/p cells, assists the Wnt pathway in regulating nuclear localization of b-catenin 9 and may provide spatial specificity. We have now identified the molecular link between b-catenin nuclear localization and the activity of the PTENAkt pathway. Akt phosphorylates b-catenin at Ser552, and the resulting p-b-cat-Ser552 form has a nuclear distribution. We also find that PTEN loss results in an increase in the number of ISC/p cells with nuclear b-catenin as well as higher levels of nuclear p-b-cat-Ser552. Moreover, ISC/p cells participating in crypt fission and crypt budding have nuclear p-b-cat-Ser552.
Precisely how phosphorylation of Ser552 influences the nuclear localization of b-catenin remains to be determined. On balance, phosphorylation of this single site may not be the sole, or even primary, determinant of b-catenin localization. Instead, we expect that additional modifications, perhaps including Akt phosphorylation at Thr217, Thr332 or Ser675, are required. The position of Ser552 within a flexible insertion interrupting Armadillo repeat (R)10 (ref. 44 ) does, however, suggest mechanisms by which phosphorylation at the Akt target site might participate in localization. The C-terminal portion of the protein, including R10, is implicated in the nuclear import and export of b-catenin 45 , and it is also suggested that conformational changes in this region help partition b-catenin between nuclear and membrane pools 46 . Phosphorylation of Ser552 may therefore modulate the translocation of b-catenin through nuclear pores or affect its conformation 47, 48 . Another possibility to consider is that phosphorylation by Akt occurs within the nucleus 49 and affects function rather than localization. Indeed, Ser552 and Ser675 are also targets of PKA 50 , and mutation of the codons encoding these sites influences transcriptional activity of b-catenin more than its localization 50 Clinical implications of the stem cell origin of polyposis An ideal cancer therapy would target cancer stem cells but not normal stem cells, but developing such a treatment requires better knowledge of the properties of both. The activity of the PTEN-Akt pathway is one distinction between these states. PTEN loss leads to an excess of overly proliferative ISC/p cells that seed the initiation of polyps, findings that bring us closer to understanding how stem cell behavior is controlled and how mutant stem cells contribute to neoplasia.
METHODS
Animal model. All animal work was performed in compliance with protocols approved by the Institutional Animal Care and Use Committee at Stowers Institute for Medical Research. We induced PTEN conditional inactivation by injecting polyinosinic-polycytidylic acid five to seven times following the procedure described previously 9 and verified targeting efficiency by PCR (Supplementary Methods online).
Tissue preparation, immunostaining and protein blot analyses. Minor modifications of the antibodies and procedures described in our previous report 9 were used here. Staining conditions for new antibodies and detailed procedures for immunohistochemical staining of nuclear b-catenin are described in Supplementary Methods. Details for protein blot analysis, TopGal staining and the generation and purification of the anti-p-b-catenin-Ser552 antibody are also described in Supplementary Methods.
Whole-mount immunofluorescent staining. Isolated intestinal crypts were fixed in 4% paraformaldehyde for 1 h at 4 1C and permeabilized using 0.5% Triton X-100 in PBS. Staining was performed as described in Supplementary Methods.
Bioinformatics and mass spectrometry. To identify potential Akt phosphorylation sites in b-catenin, we used Scansite 2.0 (Supplementary Methods) and performed a medium-stringency motif search of the human b-catenin protein sequence, which identified a single potential Akt (basophilic serinethreonine kinase) phosphorylation site at Ser552. The collision-induced dissociation spectrum for the peptide spanning Ser552 showed a major peak representing the loss of the 98-Da H 3 PO 4 group from the parent ion, indicating that Ser552 is phosphorylated by Akt (see Results and Supplementary Methods).
Microarray and RT-PCR assays. The procedures for both microarray and RT-PCR assays have been previously described (Supplementary Methods).
Microarray analysis compared the gene expression profiles of polyp regions from three PTEN-deficient animals with intestines from two controls. The programs used for gene expression analyses and gene ontology analysis are described in Supplementary Methods. Accession codes. Gene Expression Omnibus (GEO): GSE6078.
URLs. GEO: http://www.ncbi.nlm.nih.gov/projects/geo/.
Note: Supplementary information is available on the Nature Genetics website.
